In conclusion, we identified SPINK4 as not only a promising biomarker for the identification of IBD and estimation of the specific endoscopic status in colitis but also a target to ameliorate colitis by rebuilding GCs and the mucus layer via EGFR signaling and its downstream effectors. Here, SPINK4 is linked to inflammatory bowel disease.